SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse Frankfurt
Börse Börse Frankfurt
Symbol 22UA
EUR
  • BioNTech
    Börse Börse Frankfurt
    WKN
    Symbol 22UA
    EUR
  • BioNTech
    Börse Xetra Frankfurt
    Symbol 22UA
    EUR
  • BioNTech SE - ADR
    Börse Börse Berlin
    Symbol 22UA
    EUR
  • BioNTech SE - ADR
    Börse Börse München
    Symbol 22UA
    EUR
  • BIONTECH SE-ADR
    Börse Börse Stuttgart
    Symbol 22UA
    EUR
  • BIONTECH SE-ADR
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol 22UA
    EUR
  • BIONTECH SE-ADR
    Börse Börse Hamburg
    Symbol 22UA
    EUR
  • BIONTECH SE-ADR
    Börse Quotrix System der Börse Düsseldorf
    Symbol 22UA
    EUR
  • BIONTECH SE-ADR
    Börse Börse Düsseldorf
    Symbol 22UA
    EUR
  • BIONTECH SE-ADR
    Börse Gettex System der Börse München
    Symbol 22UA
    EUR
  • ISIN US09075V1026 WKN: A2PSR2
    Symbol BNTX
    USD
  • BioNTech SE - ADR
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US09075V1026
    MXN
  • BioNTech SE - ADR
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
  • BioNTech SE
    Börse London Stock Exchange
WKN
Symbol 22UA
Währung EUR
Börse Börse Frankfurt Zeitzone: Europe/Berlin
Firmenname BioNTech SE
Marktkapitalisierung 26.221.596.672
Mitarbeiter 3.165 (+- 43%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

1.800 oder 4.530 Mitarbeiter

KGV -99999.99
EBITDA 0
PEGRatio None
Buchwert None

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 299,9 EUR +1,45% 

Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat BioNTech abonniert.

Aktionärsstruktur der BioNTech SE

178 News & Informationen zur BioNTech Aktie

  • Pfizer, BioNTech join halting effort to produce covid-19 vaccines in Africa
    livemint.com

    Pfizer, BioNTech join halting effort to produce covid-19 vaccines in Africa

    Drugmakers face growing pressure from U.S., Europe to address global vaccine inequity

  • Pfizer, BioNTech Join Halting Effort to Produce Covid-19 Vaccines in Africa
    online.wsj.com

    Pfizer, BioNTech Join Halting Effort to Produce Covid-19 Vaccines in Africa

    The deal—under which the Cape Town-based Biovac Institute will fill vials of the Pfizer/BioNTech vaccine and ready them for shipment—follows growing pressure from the U.S, Europe and international organizations for drugmakers to do more to tackle global inequities in accessing Covid-19 shots.

  • Covid Rampages Through Asia; WHO’s Vaccine Target: Virus Update
    bloombergquint.com

    Covid Rampages Through Asia; WHO’s Vaccine Target: Virus Update

    (Bloomberg) — One dose of Johnson & Johnson’s Covid-19 vaccine is much less effective against the delta and lambda variants than against the original strain of the virus, the New York Times reported, citing a study that hasn’t been peer reviewed yet.

  • BioNTech SE Sponsored ADR (BNTX) Gains But Lags Market: What You Should Know
    zacks.com

    BioNTech SE Sponsored ADR (BNTX) Gains But Lags Market: What You Should Know

    In the latest trading session, BioNTech SE Sponsored ADR (BNTX) closed at $245.17, marking a +1.04% move from the previous day.

  • Immunity provided by COVID-19 vaccines likely to ‘wane, not plummet,’ CDC director tells Congress
    marketwatch.com

    Immunity provided by COVID-19 vaccines likely to ‘wane, not plummet,’ CDC director tells Congress

    Federal health officials told lawmakers it’s too soon to say whether vaccinated Americans will need a COVID-19 booster shot.

  • This ASX fund manager is predicting big things for biotech shares
    fool.com.au

    This ASX fund manager is predicting big things for biotech shares

    Platinum Asset Management Ltd's (ASX: PTM) CIO Andrew Clifford is very bullish on the future of biotech shares. Here's why

  • ?er 50 neue US-Titel im Segment ?global market?
    aktien-portal.at

    ?er 50 neue US-Titel im Segment ?global market?

    ATX (Wiener B? Index) – Über 50 neue US-Titel im Segment ?global market?

  • U.S. Cases Triple; Biden Says Misinformation Kills: Virus Update
    financialpost.com

  • FDA targets January for Pfizer COVID-19 vaccine full approval decision
    news.google.com

    FDA targets January for Pfizer COVID-19 vaccine full approval decision

    The Food and Drug Administration (FDA) will weigh full approval for the Pfizer-BioNTech COVID-19 vaccine in people aged 16 and older by January, the companies announced Friday.

  • S&P 500 Falls as Bulls in Hiding Despite Signs of Strong Consumer By Investing.com
    investing.com

    S&P 500 Falls as Bulls in Hiding Despite Signs of Strong Consumer By Investing.com

    S&P 500 Falls as Bulls in Hiding Despite Signs of Strong Consumer

  • Hit Hard by Covid-19, Southeast Asian Countries Turn to Western Vaccines
    online.wsj.com

    Hit Hard by Covid-19, Southeast Asian Countries Turn to Western Vaccines

    As vaccine supplies open up, Indonesia, Malaysia and the Philippines are shifting away from their reliance on Chinese vaccines.

  • Tokyo Olympics: Know what happens if an athlete tests Covid-19 positive
    business-standard.com

    Tokyo Olympics: Know what happens if an athlete tests Covid-19 positive

    Read more about Tokyo Olympics: Know what happens if an athlete tests Covid-19 positive on Business Standard. An athlete or a team that is forced to withdraw because of Covid will be considered 'did not start (DNS)' instead of 'disqualified'. Check Covid protocols during Olympics 2021 here

  • Worldwide RNA Therapeutics Industry - Featuring BioNTech, Moderna Therapeutics And CureVac Among Others
    thestreet.com

    Worldwide RNA Therapeutics Industry – Featuring BioNTech, Moderna Therapeutics And CureVac Among Others

    DUBLIN, July 15, 2021 /PRNewswire/ — The

  • Worldwide RNA Therapeutics Industry - Featuring BioNTech, Moderna Therapeutics and CureVac Among Others
    prnewswire.com

    Worldwide RNA Therapeutics Industry – Featuring BioNTech, Moderna Therapeutics and CureVac Among Others

    /PRNewswire/ — The

  • Delta variant drove COVID-19 cases higher across the globe last week — including in the U.S.
    marketwatch.com

    Delta variant drove COVID-19 cases higher across the globe last week — including in the U.S.

    The highly transmissible delta variant of COVID-19, now present in 111 countries, drove cases higher across the globe in the past week, including in the…

  • Countries Signal Doubts About Delta Protection From Chinese Vaccine
    online.wsj.com

    Countries Signal Doubts About Delta Protection From Chinese Vaccine

    Thailand and Indonesia say they will give a booster shot to healthcare workers who received the Sinovac inoculation.

  • Israel Sees No Need to Administer Third Pfizer Shots to Everyone
    bloombergquint.com

    Israel Sees No Need to Administer Third Pfizer Shots to Everyone

    (Bloomberg) — Israel maintains that two shots of the Pfizer vaccine are sufficient for the majority of its population, and is only planning to give a third round to patients with weakened immune systems, according to a senior adviser to the country’s Health Ministry.

  • Japan to provide millions more vaccine doses to Taiwan, Asian neighbors
    financialpost.com

    Japan to provide millions more vaccine doses to Taiwan, Asian neighbors

    TOKYO — Japan will make additional donations of the AstraZeneca Plc COVID-19 vaccine to Taiwan and other Asian neighbors this week, Foreign Minister Toshimitsu…

  • Living with COVID-19: Israel changes strategy as Delta variant hits By Reuters
    investing.com

    Living with COVID-19: Israel changes strategy as Delta variant hits By Reuters

    Living with COVID-19: Israel changes strategy as Delta variant hits

  • U.S. puts new warning on J&J coronavirus vaccine for autoimmune disorder By Reuters
    investing.com

    U.S. puts new warning on J&J coronavirus vaccine for autoimmune disorder By Reuters

    U.S. puts new warning on J&J coronavirus vaccine for autoimmune disorder

  • Pfizer/BioNTech bid for booster doses premature, more data needed
    investing.com

    Pfizer/BioNTech bid for booster doses premature, more data needed

    Analysis – Pfizer/BioNTech bid for booster doses premature, more data needed – experts

  • Politics, health collided in Taiwan's tortured BioNTech vaccine talks By Reuters
    investing.com

    Politics, health collided in Taiwan's tortured BioNTech vaccine talks By Reuters

    Politics, health collided in Taiwan's tortured BioNTech vaccine talks

  • BioNTech : 10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region
    marketscreener.com

    BioNTech : 10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region

    SHANGHAI, CHINA and MAINZ, GERMANY, July 12, 2021 – BioNTech SE announced that Fosun Industrial Co., Limited , a wholly owned subsidiary of its partner Shanghai Fosun Pharmaceutical Co., Ltd…. | July 12, 2021

  • Israel offers third shot of Pfizer COVID-19 vaccine to adults at risk
    moneycontrol.com

    Israel offers third shot of Pfizer COVID-19 vaccine to adults at risk

    The rapid spread of the Delta variant has sent vaccination rates in Israel back up as new infections have risen over the past month from single digits to around 450 a day, and the country has moved to fast-track its next Pfizer shipment.

  • COVID-19: Israel to begin giving third shot of Pfizer vaccine to adults at risk
    businesstoday.in

    COVID-19: Israel to begin giving third shot of Pfizer vaccine to adults at risk

    The rapid spread of the Delta variant has sent vaccination rates in Israel back up as new infections have risen over the past month from single digits to around 450 a day.

  • U.S. administers nearly 334.2 million doses of COVID-19 vaccines: CDC By Reuters
    investing.com

    U.S. administers nearly 334.2 million doses of COVID-19 vaccines: CDC By Reuters

    U.S. administers nearly 334.2 million doses of COVID-19 vaccines: CDC

  • Pfizer, U.S. health officials to discuss COVID boosters on Monday -company By Reuters
    investing.com

    Pfizer, U.S. health officials to discuss COVID boosters on Monday -company By Reuters

    Pfizer, U.S. health officials to discuss COVID boosters on Monday -company

  • Tech Firms to Buy Covid-19 Vaccines on Behalf of Taiwan’s Government
    online.wsj.com

    Tech Firms to Buy Covid-19 Vaccines on Behalf of Taiwan’s Government

    The roundabout arrangement with TSMC and Foxconn effectively ends a monthslong geopolitical impasse over whether Taiwan could buy vaccines directly from BioNTech.

  • Israel offers Pfizer COVID-19 vaccine booster shots to adults at risk
    livemint.com

    Israel offers Pfizer COVID-19 vaccine booster shots to adults at risk

    The rapid spread of the Delta variant has sent vaccination rates in Israel back up as new infections have risen over the past month from single digits to around 450 a day, and the country has moved to fast-track its next Pfizer shipment

  • TSMC, Foxconn say they are in process of signing deal for BioNTech COVID-19 vaccines By Reuters
    investing.com

    TSMC, Foxconn say they are in process of signing deal for BioNTech COVID-19 vaccines By Reuters

    TSMC, Foxconn say they are in process of signing deal for BioNTech COVID-19 vaccines

  • TSMC says it is in the process of signing a deal for BioNTech COVID-19 vaccines
    livemint.com

    TSMC says it is in the process of signing a deal for BioNTech COVID-19 vaccines

    Taiwan's government has tried for months to buy the vaccine directly from BioNTech and has blamed China, which claims the self-ruled island as its own territory, for nixing a deal the two sides were due to sign earlier this year

  • U.S. administers nearly 333.6 million doses of COVID-19 vaccines- CDC By Reuters
    investing.com

    U.S. administers nearly 333.6 million doses of COVID-19 vaccines- CDC By Reuters

    U.S. administers nearly 333.6 million doses of COVID-19 vaccines- CDC

  • Australia’s Delta Outbreak Shows Vaccines Protect Against Hospitalization
    online.wsj.com

    Australia’s Delta Outbreak Shows Vaccines Protect Against Hospitalization

    Early data from Australia’s outbreak of the Covid-19 Delta variant suggest that two vaccine doses offer significant protection against severe illness and hospitalization.

  • Facebook, JPMorgan Chase, Netflix: Stocks That Defined the Week
    online.wsj.com

    Facebook, JPMorgan Chase, Netflix: Stocks That Defined the Week

    Here are seven major companies whose stocks moved on the week’s news.

  • U.S. Covid-19 hospitalizations rise as Delta Variant spreads
    livemint.com

    U.S. Covid-19 hospitalizations rise as Delta Variant spreads

    Daily admissions rose 6.8% after long decline, while outbreaks among unvaccinated pushed up new cases

  • 28 Stocks Moving in Friday's Pre-Market Session
    markets.businessinsider.com

    28 Stocks Moving in Friday's Pre-Market Session

    Gainers Toughbuilt Industries Inc (NASDAQ:TBLT) shares rose 61% to $1.16 in pre-market trading after the company reported 1H sales through Amazo…

  • PRESS DIGEST-New York Times business news - July 9
    news.google.com

    PRESS DIGEST-New York Times business news – July 9

    The following are the top stories on the New York Times business pages. – Pfizer Inc and BioNTech SE said they were developing a version of the coronavirus vaccine that targets Delta, a highly contagious variant that has spread to nearly 100 countries. – Under fire for approving a questionable drug for all Alzheimer's patients, the U.S. Food and Drug Administration greatly narrowed its previous recommendation for the usage of Biogen Inc's drug Aduhelm and is now suggesting that only those with mild memory or thinking problems should receive it.

  • Pfizer Outlines Booster Plans While Regulators Signal Caution
    bloombergquint.com

    Pfizer Outlines Booster Plans While Regulators Signal Caution

    (Bloomberg) — Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its Covid-19 vaccine, based on early data showing that it can sharply increase immune protection against the coronavirus.

  • CDC says no need for booster shots as Pfizer seeks 3rd dose authorisation
    livemint.com

    CDC says no need for booster shots as Pfizer seeks 3rd dose authorisation

    This came after Pfizer Inc said on Thursday that it will US authorisation for a third dose of its Covid-19 vaccine within the next month

  • Asian Stocks Down, COVID Variants Continue to Spread By Investing.com
    investing.com

    Asian Stocks Down, COVID Variants Continue to Spread By Investing.com

    Asian Stocks Down, COVID Variants Continue to Spread

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der BioNTech Aktie

Das Unternehmen BioNTech SE aus Deutschland beschäftigt 3.165 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.

Mit einem Streubesitz von lediglich 19,7% ist der free float der Aktie vergleichsweise gering. Ein genauerer Blick in die Aktionärsstruktur könnte nützlich sein um den geringen Streubesitz vielleicht aufzuklären.

Das Unternehmen BioNTech SE ist nur in 5 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet BioNTech mit 6,85% im ETF.

5 ETFs die in BioNTech investieren

Dir gefallen die Informationen zu BioNTech?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu BioNTech?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu BioNTech?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu BioNTech?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic